Adult diagnoses (age 15 through 124)

Adult diagnoses (age 15 through 124). — See additional coding rules

T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
T45.0X6A Underdosing of antiallergic and antiemetic drugs, initial encounter
T45.0X6D Underdosing of antiallergic and antiemetic drugs, subsequent encounter
T45.0X6S Underdosing of antiallergic and antiemetic drugs, sequela
T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.1X6A Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X6D Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X6S Underdosing of antineoplastic and immunosuppressive drugs, sequela
T45.2X5A Adverse effect of vitamins, initial encounter
T45.2X5D Adverse effect of vitamins, subsequent encounter
T45.2X5S Adverse effect of vitamins, sequela
T45.2X6A Underdosing of vitamins, initial encounter
T45.2X6D Underdosing of vitamins, subsequent encounter
T45.2X6S Underdosing of vitamins, sequela
T45.3X5A Adverse effect of enzymes, initial encounter
T45.3X5D Adverse effect of enzymes, subsequent encounter
T45.3X5S Adverse effect of enzymes, sequela
T45.3X6A Underdosing of enzymes, initial encounter
T45.3X6D Underdosing of enzymes, subsequent encounter
T45.3X6S Underdosing of enzymes, sequela
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T45.4X5D Adverse effect of iron and its compounds, subsequent encounter
T45.4X5S Adverse effect of iron and its compounds, sequela
T45.4X6A Underdosing of iron and its compounds, initial encounter
T45.4X6D Underdosing of iron and its compounds, subsequent encounter
T45.4X6S Underdosing of iron and its compounds, sequela
T45.515A Adverse effect of anticoagulants, initial encounter
T45.515D Adverse effect of anticoagulants, subsequent encounter
T45.515S Adverse effect of anticoagulants, sequela
T45.516A Underdosing of anticoagulants, initial encounter
T45.516D Underdosing of anticoagulants, subsequent encounter
T45.516S Underdosing of anticoagulants, sequela
T45.525A Adverse effect of antithrombotic drugs, initial encounter
T45.525D Adverse effect of antithrombotic drugs, subsequent encounter
T45.525S Adverse effect of antithrombotic drugs, sequela
T45.526A Underdosing of antithrombotic drugs, initial encounter
T45.526D Underdosing of antithrombotic drugs, subsequent encounter
T45.526S Underdosing of antithrombotic drugs, sequela
T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.606A Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter
T45.606D Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.606S Underdosing of unspecified fibrinolysis-affecting drugs, sequela
T45.615A Adverse effect of thrombolytic drugs, initial encounter
T45.615D Adverse effect of thrombolytic drugs, subsequent encounter
T45.615S Adverse effect of thrombolytic drugs, sequela
T45.616A Underdosing of thrombolytic drugs, initial encounter
T45.616D Underdosing of thrombolytic drugs, subsequent encounter
T45.616S Underdosing of thrombolytic drugs, sequela
T45.625A Adverse effect of hemostatic drug, initial encounter
T45.625D Adverse effect of hemostatic drug, subsequent encounter
T45.625S Adverse effect of hemostatic drug, sequela
T45.626A Underdosing of hemostatic drugs, initial encounter
T45.626D Underdosing of hemostatic drugs, subsequent encounter
T45.626S Underdosing of hemostatic drugs, sequela
T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.696A Underdosing of other fibrinolysis-affecting drugs, initial encounter
T45.696D Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
T45.696S Underdosing of other fibrinolysis-affecting drugs, sequela
T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.7X6A Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
T45.7X6D Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
T45.7X6S Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter
T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
T45.8X6A Underdosing of other primarily systemic and hematological agents, initial encounter
T45.8X6D Underdosing of other primarily systemic and hematological agents, subsequent encounter
T45.8X6S Underdosing of other primarily systemic and hematological agents, sequela
T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
T45.96XA Underdosing of unspecified primarily systemic and hematological agent, initial encounter
T45.96XD Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
T45.96XS Underdosing of unspecified primarily systemic and hematological agent, sequela
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.0X6A Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X6S Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
T46.1X5S Adverse effect of calcium-channel blockers, sequela
T46.1X6A Underdosing of calcium-channel blockers, initial encounter
T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter
T46.1X6S Underdosing of calcium-channel blockers, sequela
T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
T46.2X6A Underdosing of other antidysrhythmic drugs, initial encounter
T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter
T46.2X6S Underdosing of other antidysrhythmic drugs, sequela